This article is more than 5 years old. Information may no longer be current.
Center opens new oncology program
Click Here to Manage Email Alerts
Diana Simeone
The University of Michigan Comprehensive Cancer Center will open a new translational oncology program.
The program is designed to bring together cancer researchers from across the university campus to speed the translation of basic science research into clinical trials and new treatment opportunities for patients.
Diana Simeone, MD, the Lazar J. Greenfield Professor of Surgery at the university’s medical school, has been named director of the program.
“Important discoveries are going to come from looking at cancer from many different angles,” Simeone said in a press release. “This program will bring together scientists from different areas and allow us to approach cancer from all angles.”
Up to 40 investigators will be part of the program. They will focus on experimental therapeutics, cancer stem cells, molecular imaging and genomics.
Max S. Wicha
The program also will work closely with industry to facilitate drug development and early phase testing of potential new cancer treatments.
“The translational oncology program represents a major hub for cancer research and a tremendous opportunity to facilitate new discoveries for patients,” Max S. Wicha, MD, director of the university’s Comprehensive Cancer Center, said in the release. “Identifying and understanding the molecular pathways at work in cancer, and targeting treatments to these pathways, represents the future of cancer care.”